Continous Blood Glucose Monitoring Global Market Report 2024

Description

“Continuous Blood Glucose Monitoring Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous blood glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous blood glucose monitoring? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The continuous blood glucose monitoring market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Component: Insulin Pumps; Sensors; Transmitters; Receivers
2) By Application: Type 1 Diabetic Patients; Type 2 Diabetic Patients; Gestational Diabetes; Critical Care Patients
3) By End User: Hospitals; Homecare Diagnostics; Other End Users
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Lifescan Inc.; Medtronic plc.; Abbott Laboratories; GlySens Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

A continuous blood glucose monitoring device plays a crucial role in helping individuals better regulate glucose levels throughout the day, leading to fewer instances of low blood glucose situations.

The main components in continuous blood glucose monitoring devices include insulin pumps, sensors, transmitters, and receivers. Insulin pumps are compact, computerized devices that are programmed to administer pre-determined doses of insulin at specific intervals. These devices are particularly utilized by individuals with type 1 diabetes, type 2 diabetes, gestational diabetes, and critical care patients. The end-users for continuous blood glucose monitoring devices include hospitals, homecare diagnostics, and various other settings.

The continuous blood glucose monitoring market research report is one of a series of new reports from The Business Research Company that provides continuous blood glucose monitoring market statistics, including continuous blood glucose monitoring industry global market size, regional shares, competitors with a continuous blood glucose monitoring market share, detailed continuous blood glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous blood glucose monitoring industry. This continuous blood glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continous blood glucose monitoring market size has grown rapidly in recent years. It will grow from $8.09 in 2023 to $9.68 in 2024 at a compound annual growth rate (CAGR) of 19.7%. The growth observed in the historical period in the continuous blood glucose monitoring device market can be attributed to several factors, including the increase in diabetes prevalence, growing regulatory compliance, the demand for remote monitoring solutions, expansion into emerging markets, and a rise in healthcare spending. These factors collectively contributed to the expansion and adoption of continuous blood glucose monitoring devices during that time, reflecting the increasing need for effective solutions in managing diabetes and related conditions.

The continous blood glucose monitoring market size is expected to see exponential growth in the next few years. It will grow to $20.44 in 2028 at a compound annual growth rate (CAGR) of 20.5%. The anticipated growth in the forecast period in the continuous blood glucose monitoring device market can be attributed to various factors, including the growing aging population, the expansion of home healthcare services, the rise in telehealth services, increased healthcare expenditure, and a general rise in disposable income. Major trends expected during this period include the integration of wearable technologies, the incorporation of artificial intelligence and machine learning, advancements in sensor technology for enhanced accuracy, and increased partnerships and collaborations within the healthcare industry. These trends collectively indicate a dynamic and evolving landscape in continuous blood glucose monitoring, reflecting advancements in technology and collaborative efforts to improve healthcare outcomes.

The continuous blood glucose monitoring market is anticipated to experience growth, propelled by the increasing prevalence of diabetes. Diabetes, a health condition characterized by fluctuating blood glucose levels, can benefit significantly from the use of blood glucose monitoring devices. These devices aid in detecting trends and patterns, offering a comprehensive view of a diabetic individual's condition. The International Diabetes Federation (IDF) reported in its IDF Diabetes Atlas 10th edition in July 2021 that the estimated global population of individuals living with diabetes is projected to reach 643 million by 2030 and further increase to 783 million by 2045. This rise, from approximately 537 million adults in 2021, highlights the escalating prevalence of diabetes as a driving force behind the continuous blood glucose monitoring market's growth.

The proliferation of hospitals is poised to contribute to the expansion of the continuous blood glucose monitoring market. Hospitals, dedicated to providing medical or surgical treatment, find continuous blood glucose monitoring crucial for precise and ongoing monitoring of blood glucose levels, particularly for patients with diabetes or those at risk of glucose-related complications. According to Discovery Therapy in September 2023, the US had around 6,090 hospitals in 2021, while globally, there were approximately 165,000 hospitals. Additionally, the American Hospital Association reported in May 2023 that there were 6,129 hospitals in America in 2022. The increased number of hospitals globally is expected to drive the growth of the continuous blood glucose monitoring market.

Technological advancements emerge as a significant trend shaping the continuous blood glucose monitoring market. Key players in the market are actively engaged in developing advanced technological solutions to enhance their market presence. In 2021, Philips, a Netherlands-based health technology company specializing in glucose monitoring devices, launched non-invasive monitors for COPD patients based on ExpiraFlow technology. These non-invasive monitors enable healthcare professionals to detect and screen expiratory flow limitations, offering a valuable tool for optimal home care therapy. This focus on technological innovation underscores the commitment of major companies to staying at the forefront of the continuous blood glucose monitoring market.

Prominent companies in the diabetes care devices market are actively pursuing innovation with the introduction of new products, exemplified by the Medtronic Extended infusion set, aimed at enhancing their profitability. The Medtronic Extended infusion set is a tubing system designed to deliver insulin from the pump to the body and boasts a wear duration of up to 7 days. Medtronic Plc., a US-based medical equipment manufacturer, launched this product in select European countries in April 2021. Initially available for purchase in specific European nations, including Finland and Belgium, the product is set for a gradual rollout to additional European countries. The Medtronic Extended infusion set includes an all-in-one serter, streamlining the process of changing the set and making it fast and straightforward. Notably, its innovative technology and alternative materials allow for double the wear duration compared to other Medtronic infusion sets, typically approved for 2-3 days of use.

In a strategic move in May 2023, Medtronic PLC., an Ireland-based medical device company, acquired EOFlow for an undisclosed amount. This acquisition is geared towards strengthening Medtronic's diabetes product portfolio and expanding its capacity to offer comprehensive support to a larger global community managing diabetes, all within a unified Medtronic ecosystem. EOFlow Co. Ltd., based in South Korea, is recognized for manufacturing the insulin patch pump EOPatch. This strategic acquisition aligns with Medtronic's commitment to continuous growth and innovation in the diabetes care devices market.

Major companies operating in the continous blood glucose monitoring market include F. Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic plc., Abbott Laboratories, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Goldsite Diagnostics Inc., AgaMatrix Inc., B. Braun Melsungen AG, Ypsomed Holding AG, Terumo Corporation, Orsense Ltd., Dexcom Inc., A. Menarini Diagnostics, Echo Therapeutics Inc., Johnson & Johnson Services Inc., Ascensia Diabetes Care Holdings AG, Insulet Corporation, Medtrum Technologies Inc., Texas Instruments Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., One Drop Inc., DarioHealth Corp., MedAngel BV, GluSense Ltd., PKvitality, Nemotecnia S.A.

North America was the largest region in the continuous blood glucose monitoring market in 2023. The regions covered in the continuous blood glucose monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the continuous blood glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The continuous blood glucose monitoring market consists of sales of real-time continuous glucose monitoring, and intermittently scanned continuous glucose monitoring. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r9490

1. Executive Summary

2. Continuous Blood Glucose Monitoring Market Characteristics

3. Continuous Blood Glucose Monitoring Market Trends And Strategies

4. Continuous Blood Glucose Monitoring Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Continuous Blood Glucose Monitoring Market Size and Growth

5.1. Global Continuous Blood Glucose Monitoring Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Continuous Blood Glucose Monitoring Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Continuous Blood Glucose Monitoring Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Continuous Blood Glucose Monitoring Market Segmentation

6.1. Global Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Insulin Pumps
Sensors
Transmitters
Receivers
6.2. Global Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Type 1 Diabetic Patients
Type 2 Diabetic Patients
Gestational Diabetes
Critical Care Patients
6.3. Global Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare Diagnostics
Other End Users

7. Continuous Blood Glucose Monitoring Market Regional And Country Analysis

7.1. Global Continuous Blood Glucose Monitoring Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Continuous Blood Glucose Monitoring Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Continuous Blood Glucose Monitoring Market

8.1. Asia-Pacific Continuous Blood Glucose Monitoring Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Continuous Blood Glucose Monitoring Market

9.1. China Continuous Blood Glucose Monitoring Market Overview
9.2. China Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Continuous Blood Glucose Monitoring Market

10.1. India Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Continuous Blood Glucose Monitoring Market

11.1. Japan Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Continuous Blood Glucose Monitoring Market

12.1. Australia Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Continuous Blood Glucose Monitoring Market

13.1. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Continuous Blood Glucose Monitoring Market

14.1. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Continuous Blood Glucose Monitoring Market

15.1. Western Europe Continuous Blood Glucose Monitoring Market Overview
15.2. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Continuous Blood Glucose Monitoring Market

16.1. UK Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Continuous Blood Glucose Monitoring Market

17.1. Germany Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Continuous Blood Glucose Monitoring Market

18.5. France Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Continuous Blood Glucose Monitoring Market

19.9. Italy Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Continuous Blood Glucose Monitoring Market

20.13. Spain Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Continuous Blood Glucose Monitoring Market

21.1. Eastern Europe Continuous Blood Glucose Monitoring Market Overview
21.2. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Continuous Blood Glucose Monitoring Market

22.1. Russia Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Continuous Blood Glucose Monitoring Market

23.1. North America Continuous Blood Glucose Monitoring Market Overview
23.2. North America Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Continuous Blood Glucose Monitoring Market

24.1. USA Continuous Blood Glucose Monitoring Market Overview
24.2. USA Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Continuous Blood Glucose Monitoring Market

25.1. Canada Continuous Blood Glucose Monitoring Market Overview
25.2. Canada Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Continuous Blood Glucose Monitoring Market

26.1. South America Continuous Blood Glucose Monitoring Market Overview
26.2. South America Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Continuous Blood Glucose Monitoring Market

27.1. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Continuous Blood Glucose Monitoring Market

28.1. Middle East Continuous Blood Glucose Monitoring Market Overview
28.2. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Continuous Blood Glucose Monitoring Market

29.1. Africa Continuous Blood Glucose Monitoring Market Overview
29.2. Africa Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Continuous Blood Glucose Monitoring Market Competitive Landscape And Company Profiles

30.1. Continuous Blood Glucose Monitoring Market Competitive Landscape
30.2. Continuous Blood Glucose Monitoring Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Lifescan Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Medtronic plc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Abbott Laboratories
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. GlySens Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Continuous Blood Glucose Monitoring Market Competitive Benchmarking

32. Global Continuous Blood Glucose Monitoring Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Continuous Blood Glucose Monitoring Market

34. Continuous Blood Glucose Monitoring Market Future Outlook and Potential Analysis

34.1 Continuous Blood Glucose Monitoring Market In 2028 - Countries Offering Most New Opportunities
34.2 Continuous Blood Glucose Monitoring Market In 2028 - Segments Offering Most New Opportunities
34.3 Continuous Blood Glucose Monitoring Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer